Why Globus Medical, Inc. (GMED) stock moved
Globus Medical, Inc. (GMED) shares rose 1.4% to $76.49 as of July 25, 2026, a modest gain from the prior close of $75.42. BestStocks flagged the session as a major change for GMED. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for GMED, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
GMED climbed 1.4% to $76.49
GMED rose 1.4% in its latest session, moving from $75.42 to $76.49.
What it means for Globus Medical, Inc. investors
For Globus Medical, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Material positive event; Positive 1.4% session move. Weighing against that: Globus Medical, Inc. (GMED) moved -4.83% from $80.91 to $77.00 on 2026-07-17; Globus Medical, Inc. (GMED) moved -4.93% from $79.75 to $75.82 on 2026-07-14. Wall Street's consensus price target sits at $102.38, implying +33.8% upside from $76.49. BestStocks rates the overall signal quality low (40/100). With earnings roughly 12 days out, the next report is the most likely near-term test of the move.
GMED price reaction
GMED last traded at $76.49, up $1.07 (+1.42%) from the previous close of $75.42. The session traded on 0.9× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $75.42 and $86.25, and it currently sits about 10% of the way up that band.
Bullish and bearish analyst opinions on Globus Medical, Inc. (GMED)
The consensus analyst price target on Globus Medical, Inc. (GMED) is $102.38, 33.8% above the recent $76.49. Over the past 90 days analysts logged 0 upgrades, 7 maintains, and 0 downgrades. Here is how the bullish and bearish cases on GMED line up.
The bullish case
- Wall Street's consensus price target of $102.38 implies +33.8% upside from $76.49.
- The Street's most bullish target is $117.00 (+53.0%).
- Material positive event.
- Positive 1.4% session move.
- Globus Medical, Inc. (GMED) moved +2.99% from $78.56 to $80.91 on 2026-07-16.
The bearish case
- Globus Medical, Inc. (GMED) moved -4.83% from $80.91 to $77.00 on 2026-07-17.
- GMED moved -3.34% from $78.83 to $76.20 on 2026-07-08.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 25, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for GMED
Frequently asked questions about GMED
Why did Globus Medical, Inc. (GMED) stock move?
GMED rose 1.4% to $76.49. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did GMED stock rise?
GMED gained 1.42% ($1.07) versus the prior close of $75.42, last trading at $76.49 on 0.9× average volume.
When is Globus Medical, Inc.'s next earnings date?
GMED's next earnings report is estimated for 2026-08-06 — about 12 days away.
What is the analyst price target for GMED?
The consensus analyst price target for GMED is $102.38, about 33.8% above the current $76.49. Over the past 90 days, analysts recorded 0 upgrades, 7 maintains, and 0 downgrades.
How BestStocks tracks GMED
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared GMED-specific materiality thresholds, triggering an evidence check. It draws on 11 tracked change events for GMED, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 25, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.